PubChem 1-Testosterone Cypionate CID 16219612 monograph
NIH PubChem
Injectable muscle-building steroid never approved as a medicine; no human studies exist and it is banned in sport.


The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
DHB (Dihydroboldenone, also known as 1-Testosterone) is an anabolic, meaning muscle-building, steroid and a close relative of the steroid boldenone. It has never been an approved medicine, either for humans or for animals, and exists only on the black market, as an injection. In the European Union, including Hungary and Poland, it is a controlled substance that is illegal without a prescription, and in competitive sport it is banned all year round.
Unlike boldenone, it does not turn into estrogen, and it puts little strain on the liver. It has strong male-hormone effects: it can cause acne and faster hair loss, worsens cholesterol values, raises blood pressure, and suppresses the body's own testosterone production, which leads to shrinking testicles and fertility problems. It is notorious for pain and swelling at the injection site that last for days. No human study has been done with it, and its effects are inferred from related drugs, so its long-term safety is unknown. In women it causes partly irreversible masculinization, and it must not be used in pregnancy.
Mechanism
AR agonist, 1-Testosterone (Δ1-DHT), NOT aromatized
Anabolic:Androgenic
200:100
Half-life
8-10 days (Cypionate ester)
Onset
48-72 h (IM)
Legal status
UGL only, no Rx approval. WADA-banned.
No anecdote collected yet.
Data console
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. . Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341-75..
Hartgens F, Kuipers H. . Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-554..
Schänzer W. . Metabolism of anabolic androgenic steroids. Clin Chem. 1996;42(7):1001-20..
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. . Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104(12):1966-78..
Rahnema CD, Crosnoe LE, Kim ED . Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem. Andrology. 2015;3(2):150-5..
NIH PubChem . PubChem 1-Testosterone Cypionate CID 16219612 monograph. PubChem Open Chemistry Database.
Safety
Side effects · 7
Contraindications · 7
Related Performance Compounds
Studies
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S.
Hartgens F, Kuipers H.
Schänzer W.
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr.
Rahnema CD, Crosnoe LE, Kim ED
NIH PubChem
Telegram
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.